Dutoit V - Search Results

1

T-cell immunotherapy for malignant glioma: toward a combined approach.

Dietrich PY, Dutoit V, Tran Thang NN, Walker PR. Dietrich PY, et al. Among authors: dutoit v. Curr Opin Oncol. 2010 Nov;22(6):604-10. doi: 10.1097/CCO.0b013e32833dead8. Curr Opin Oncol. 2010. PMID: 20739889 Review.

2

Promises and Challenges of Predictive Blood Biomarkers for Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy.

Machado Carvalho JV, Dutoit V, Corrò C, Koessler T. Machado Carvalho JV, et al. Among authors: dutoit v. Cells. 2023 Jan 26;12(3):413. doi: 10.3390/cells12030413. Cells. 2023. PMID: 36766755 Free PMC article. Review.

3

Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients.

Valmori D, Dutoit V, Liénard D, Lejeune F, Speiser D, Rimoldi D, Cerundolo V, Dietrich PY, Cerottini JC, Romero P. Valmori D, et al. Among authors: dutoit v. J Immunol. 2000 Jul 1;165(1):533-8. doi: 10.4049/jimmunol.165.1.533. J Immunol. 2000. PMID: 10861093

4

Melanoma patients respond to a cytotoxic T lymphocyte-defined self-peptide with diverse and nonoverlapping T-cell receptor repertoires.

Dietrich PY, Walker PR, Quiquerez AL, Perrin G, Dutoit V, Liénard D, Guillaume P, Cerottini JC, Romero P, Valmori D. Dietrich PY, et al. Among authors: dutoit v. Cancer Res. 2001 Mar 1;61(5):2047-54. Cancer Res. 2001. PMID: 11280765

5

Heterogeneous T-cell response to MAGE-A10(254-262): high avidity-specific cytolytic T lymphocytes show superior antitumor activity.

Dutoit V, Rubio-Godoy V, Dietrich PY, Quiqueres AL, Schnuriger V, Rimoldi D, Liénard D, Speiser D, Guillaume P, Batard P, Cerottini JC, Romero P, Valmori D. Dutoit V, et al. Cancer Res. 2001 Aug 1;61(15):5850-6. Cancer Res. 2001. PMID: 11479225

6

Circulating Tumor-reactive CD8(+) T cells in melanoma patients contain a CD45RA(+)CCR7(-) effector subset exerting ex vivo tumor-specific cytolytic activity.

Valmori D, Scheibenbogen C, Dutoit V, Nagorsen D, Asemissen AM, Rubio-Godoy V, Rimoldi D, Guillaume P, Romero P, Schadendorf D, Lipp M, Dietrich PY, Thiel E, Cerottini JC, Liénard D, Keilholz U. Valmori D, et al. Among authors: dutoit v. Cancer Res. 2002 Mar 15;62(6):1743-50. Cancer Res. 2002. PMID: 11912149

7

Vaccination with a Melan-A peptide selects an oligoclonal T cell population with increased functional avidity and tumor reactivity.

Valmori D, Dutoit V, Schnuriger V, Quiquerez AL, Pittet MJ, Guillaume P, Rubio-Godoy V, Walker PR, Rimoldi D, Liénard D, Cerottini JC, Romero P, Dietrich PY. Valmori D, et al. Among authors: dutoit v. J Immunol. 2002 Apr 15;168(8):4231-40. doi: 10.4049/jimmunol.168.8.4231. J Immunol. 2002. PMID: 11937585

8

Degeneracy of antigen recognition as the molecular basis for the high frequency of naive A2/Melan-a peptide multimer(+) CD8(+) T cells in humans.

Dutoit V, Rubio-Godoy V, Pittet MJ, Zippelius A, Dietrich PY, Legal FA, Guillaume P, Romero P, Cerottini JC, Houghten RA, Pinilla C, Valmori D. Dutoit V, et al. J Exp Med. 2002 Jul 15;196(2):207-16. doi: 10.1084/jem.20020242. J Exp Med. 2002. PMID: 12119345 Free PMC article.

9

Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma.

Romero P, Valmori D, Pittet MJ, Zippelius A, Rimoldi D, Lévy F, Dutoit V, Ayyoub M, Rubio-Godoy V, Michielin O, Guillaume P, Batard P, Luescher IF, Lejeune F, Liénard D, Rufer N, Dietrich PY, Speiser DE, Cerottini JC. Romero P, et al. Among authors: dutoit v. Immunol Rev. 2002 Oct;188:81-96. doi: 10.1034/j.1600-065x.2002.18808.x. Immunol Rev. 2002. PMID: 12445283 Review.

10

Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigen.

Dietrich PY, Le Gal FA, Dutoit V, Pittet MJ, Trautman L, Zippelius A, Cognet I, Widmer V, Walker PR, Michielin O, Guillaume P, Connerotte T, Jotereau F, Coulie PG, Romero P, Cerottini JC, Bonneville M, Valmori D. Dietrich PY, et al. Among authors: dutoit v. J Immunol. 2003 May 15;170(10):5103-9. doi: 10.4049/jimmunol.170.10.5103. J Immunol. 2003. PMID: 12734356

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85 results

Search Page